Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06781749 · ClinicalTrials.gov registry record

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

A clinical trial of Hearing Loss, Bilateral (Causes Other Than Tumors), sponsored by University of Southern California.

Recruiting
Registry status
100
Enrollment target
2
Study locations

NCT06781749: Recruiting study of Hearing Loss, Bilateral (Causes Other Than Tumors), sponsored by University of Southern California.

NCT06781749 is a study of Hearing Loss, Bilateral (Causes Other Than Tumors) that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 100 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06781749, a study of Hearing Loss, Bilateral (Causes Other Than Tumors), is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
100 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to learn if hearing devices, like hearing aids, affect social and cognitive function of older adults. The main questions the researchers want to answer are: * How social are older adults with hearing loss before and after using hearing devices? * How well do older adults with hearing loss think before and after using hearing devices? * For older adults who have hearing loss and use hearing devices, do changes in social interaction explain changes in how well they think (cognitive function)? * Do brainwaves (EEGs) in older adults with hearing loss change after using hearing devices? * Are there differences in how social older adults with hearing loss are compared to older adults without hearing loss? What Participants Will Do: * Participants will take questionnaires for around 60 minutes. Questionnaires will ask participants about their background, health, hearing, and how social they are. Another set of questionnaires will check their thinking ability or cognition. * Participants will wear an audio sensor (TILES Audio Recorder on Jelly Mobile phone) for 2 weeks. The sensor will collect and store information about a participant's voice during conversations. Once the device has information about a participant's voice such as pitch and tone it will store this information and delete the audio recording. Words spoken during conversations will be deleted. * (Optional) Participants can choose to participate in a 45-60-minute EEG (electroencephalogram) recording session. Participants will have sensors placed on top of their heads. Sensors will record the participants' brainwaves. Sounds will be played to see how participants' brainwaves change when they hear sounds. Eligible participants will be invited to participate in 4-month follow-up study.

Primary Outcome

The audio sensor employs deep-learning-based multimodal speech pattern modeling of participants' own voice activities to extract speech arousal and speech activities. Speech activity measures include the intersession time (the interval between speech sessions, representing the frequency of conversation engagement).

Interventions

  • DEVICE Hearing aid use

Study Locations (2)

California

  • Los Angeles General Medical Center - Los Angeles
  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-01-01
Est. Completion 2030-06-30
University of Southern California

617 total trials

What NCT06781749 shows while recruiting

NCT06781749 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Hearing Loss, Bilateral (Causes Other Than Tumors) appearing as the primary indexed condition, and to 1 intervention - of which Hearing aid use is the first listed.

NCT06781749 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06781749 about?

NCT06781749 is a clinical study titled "New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss". The goal of this clinical trial is to learn if hearing devices, like hearing aids, affect social and cognitive function of older adults. The main questions the researchers want to answer are: * How social are older adults with hearing loss before and after using hearing devices? * How well do older...

What is the current status of trial NCT06781749?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-01-01. Estimated completion is 2030-06-30.

What conditions does trial NCT06781749 study?

This clinical trial studies the following conditions: Hearing Loss, Bilateral (Causes Other Than Tumors).

What interventions are being tested in trial NCT06781749?

The interventions under investigation include: Hearing aid use (DEVICE).

Who is sponsoring clinical trial NCT06781749?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06781749 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Bilateral (Causes Other Than Tumors)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06781749, the US trial registry maintained by the National Library of Medicine. NCT06781749 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.